chr16-23607914-A-G
Variant summary
The NM_024675.4(PALB2):c.3300T>C (p.Thr1100Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★).
Frequency
Consequence
NM_024675.4 synonymous
Scores
Clinical Significance
Conservation
Publications
- hereditary breast carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- PALB2-related cancer predispositionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Fanconi anemia complementation group NInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Ambry Genetics
- pancreatic cancer, susceptibility to, 3Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Benign. The variant received -7 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PM2Absent/extremely low in population databases | Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (base 0.0001, raised to 0.000208 by highest known P/LP ClinVar AF 0.000208) — PM2 moderate. | ||
| BP4Computational evidence suggests no impact | Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong). | ||
| BP6Reputable source reports benign | ClinVar 2-star benign — strong (BP6); ClinVar germline classification: Benign/Likely Benign, 2 star(s). | ||
| BP7Synonymous variant, no splicing impact | Synonymous variant at non-conserved position with no predicted splicing impact (BP7); Synonymous at non-conserved position, no splicing concern — benign (BP7). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_024675.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
PALB2 | MANE Select | c.3300T>C p.Thr1100Thr | synonymous | Exon 12 of 13 | Prot: NP_078951.2 | |
PALB2 | c.3240T>C p.Thr1080Thr | synonymous | Exon 11 of 12 | Prot: NP_001394225.1 | ||
PALB2 | c.3228T>C p.Thr1076Thr | synonymous | Exon 11 of 12 | Prot: NP_001394226.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
PALB2 | TSL:1MANE Select | c.3300T>C p.Thr1100Thr | synonymous | Exon 12 of 13 | Prot: ENSP00000261584.4 UniProt: | |
PALB2 | TSL:1 | c.2415T>C p.Thr805Thr | synonymous | Exon 12 of 13 | Prot: ENSP00000454703.2 UniProt: | |
PALB2 | TSL:5 | c.3306T>C p.Thr1102Thr | synonymous | Exon 12 of 13 | Prot: ENSP00000460666.3 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:31 | ||||
GnomAD4 exome | Cov:32 | ||||
GnomAD4 genome | Cov:31 | ||||
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Uncertain | 19 | |
BayesDel_noAF | Benign | -0.85 | |
CADD | Benign | 3.6 | |
DANN | Benign | 0.61 | |
GPN-Star LLR | N/A | 2.1 | |
GPN-Star score | N/A | -2.1 | |
Mutation Taster | N/A | 100/0 | polymorphism |
PhyloP100 | Benign | 0.30 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.020 | |
SpliceAI score (max) | Benign | 0.020 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
MaveDB functional evidence
- Gene
- PALB2
- Assay type
- Cell proliferation assay
- Mechanism
- Loss of function
- Model system
- Immortalized human cells
- Score
- -0.00608
- Gene
- PALB2
- Assay type
- Cell proliferation assay
- Mechanism
- Loss of function
- Model system
- Immortalized human cells
- Score
- -0.00608